Pyramid Labs
Peter Buzy holds significant experience in leadership roles, currently serving as a Member of the Board of Directors at Pyramid Labs, AeroSafe Global, and LumaCyte. Additionally, Peter Buzy contributes as an Advisory Partner for the Healthcare Fund at NewSpring and is an Advisory Board Member at Spring Capital Partners. Peter Buzy is an alumnus of Salisbury State University.
This person is not in the org chart
This person is not in any teams
Pyramid Labs
Founded in 1988, Pyramid Labs is a Drug Product CDMO specializing in injectable drug product development and manufacturing. Our capabilities include: • Clinical and Commercial Vial & Syringe Fill/Finish • Clinical and Commercial Lyophilization • Liquid Drug Product Formulation & Process Development • Lyophilized Drug Product Formulation & Cycle Development • PPQ and PV for late stage Drug Products • Labeling & Packaging • Quality Control Laboratory Services- In-process, Lot Release & Stability • Analytical Method Development & Validation • API & Drug Product Stability Studies